An approach to the design of artificial receptors is described involving the fusion of several sixmembered rings, preorganizing nitrogen and oxygen hydrogen bonding sites. A hexagonal lattice chemosensor extracts the blood metabolite creatinine into water and acts as a chromogenic reagent for this clinical analyte. Another receptor binds urea via six hydrogen bonds, forming a complex that is stable even in DMSO. A water-soluble receptor has now been synthesized that recognizes the guanidinium sidechain of arginine in aqueous media.
INTRODUCTION
Artificial receptors can be tailored to bind small, biologically-relevant molecules, such as metabolites, amino acids and nucleotides. Our host compounds are not intended to serve as models of natural receptors, carriers or enzymes. Instead, we hope to probe fundamental aspects of molecular recognition through design and synthesis of completely artificial receptors, followed by examination of the structures and stabilities of their complexes. Targeting guest molecules of biological importance also invites opportunities for practical applications of the hosts, e.g. as chemosensors (ref. 1,2) or chemotherapeutic agents.
Our approach utilizes fused-ring structures to control the molecular architecture of the host and consequently to preorganize metal-ligating atoms or hydrogen bonding sites. The high affinities of hosts that are conformationally organized for complexation and have poorly solvated binding sites were previously recognized by Cram (ref. 3). host compounds consisting of several pyridine and six-membered carbocyclic rings fused into a relatively rigid, planar molecular framework. Metal-binding host 1 (ref. We are now extending the hexagonal lattice approach to develop molecular sensors for small molecules of biological importance, including urea and creatinine. Artificial receptors for nucleotides and amino acids are also of interest as novel molecular probes and potentially as biopolymer-binding drugs.
OPTICAL CHEMOSENSORS FOR CREATININE
Blood levels of the nitrogenous metabolites urea and creatinine are used to monitor human kidney function, making these clinical analytes excellent targets for developing novel chemosensors (ref, 1,2,12), Figure 2 shows our approach to a chromogenic reagent for creatinine (5) based conceptually on urea receptor 3 (Fig. 1) . In the design of creatinine receptor 4 the righthand portion of 3 was removed and the chromogenic dinitrophenol group was incorporated into the left-hand portion. The synthesis of 4 (ref. 12) was carried out in five steps from an intermediate used in the preparation of torand 1 and related fused-ring terpyridyl ligands (ref. 13).
Creatinine is extracted from water into dichloromethane solutions of receptor 4, forming the colored complex (6). As shown in Fig. 2 , binding of creatinine by three hydrogen bonds causes a proton to be transferred from the OH group, apparently to the terminal nitrogen atom of the receptor. The receptor moiety in 6 has a delocalized, dipolar structure, producing a broad absorption band in the visible region (400-500 nm). This absorption spectrum is consistent with structure 6 found in the crystalline complex (ref. The chromogenic response of receptor 4 is sufficiently sensitive for measurement of creatinine at normal blood levels with correction for background levels of Na', which produces an 80-fold weaker response. Current research efforts are directed at improving the creatininehodium selectively and at creating fluorescent reagents for creatinine. Figure 3 shows synthetic routes for incorporating two different fluorophores into the receptor backbone. Both syntheses start with intermediate 7, which was used previously in the synthesis of a torand analog of U-shaped receptor 2 (ref. 10). FriedlSinder condensation with homophthalimide introduces the benzanthyridone fluorophore in 8, which is converted to ketone 9 by ozonolysis. In the second synthesis, intermediate 7 is converted first to free base form 10 before condensation with acetic anhydride. Ozonolysis of 11 yields ketone 12 containing a 1 &naphthyridone fluorophore.
Ketones 9 and 12 could serve as intermediates in the synthesis of fluorescent reagents containing phenolic or other acidic groups, but they are also useful as model compounds for probing optical response resulting from the incorporation of such structures as intrinsic fluorophores in hexagonal lattice receptors (ref. 1). We have examined the spectroscopic effects of protonation of ketones 9 and 12, considering that proton transfer might be used to signal binding of creatinine or other guests by receptors containing similar intrinsic fluorophores. In ethanol the emission maximum of 9 shifts from 400 to 438 run upon protonation, while that of 12 shifts from 378 to 406 nm. Addition of trifluoroacetic acid to solutions of 9 in CDCl,/methanol-d, causes the largest downfield shifts for the 'H and 13C NMR signals of the pyridine ring marked by an asterisk in Fig. 3 and protonation of 12 appears to occur at the corresponding position. The longer wavelength absorption and emission of 9 and the apparent formation of a favorable array of donor and acceptor sites upon protonation make the benzanthyridone moiety attractive for further development as an intrinsic fluorophore in receptors for creatinine and similar guest molecules.
A U-SHAPED RECEPTOR FOR UREA
Hexagonal lattice receptor design makes possible the complexation of urea via a maximum of six hydrogen bonds, as in the guanidinium complex of 2 (Fig. 1 .) , while diketone 3 only forms four hydrogen bonds with the NH donors of urea (ref. 11) . Figure 4 shows a U-shaped artificial receptor (13) that fully satisfies the hydrogen-bonding capacity of urea (ref. 15). Complex 14 is very stable, even in competitive hydrogen-bonding solvents, such as DMSO. In fact, receptor 13 is best purified after synthesis by thermal recrystallization of 14 from DMSO, followed by extraction of urea from the complex by boiling water.
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Complex 14 was characterized by combustion microanalysis and by IR spectroscopy, showing the hydrogen bonded C=O absorption at 1655 cm-' (ref. 11). Binding of urea can be followed by IH NMR spectroscopy using 1 : 1 (vh) CDCl,/DMSO-d6, but calculation of a stability constant is complicated by the concentration dependence of the chemical shifts of free 13 in this solvent mixture. Complexation also causes a 16 nm bathochromic shift of the longest wavelength absorption maximum of 13 (394 nm) and Ks = 1.4 x lo4 was obtained from titration data using 1 : 1 CHCl,/DMSO (ref. 1 1). This optical response is specific for urea; binding of N-butylurea causes small changes in the absorption spectrum of 13, which shows negligible responses to N,N'-dimethylurea and N,N-dimethylurea. Among complexes in which urea is bound solely by neutral hydrogen bonds, 14 is uniquely stable.
A WATER-SOLUBLE GUANIDINIUM RECEPTOR
Most designed receptors for the guanidinium cation are flexible, crown ether derivatives. Previously reported hexagonal lattice receptors, including guanidinium receptor 2 (Fig. l) , are extractants and membrane transport agents, but their poor water solubilities limit homogeneous binding studies to organic solvents. Lacking alkyl sidechains, dicarboxylic acid 15 was expected to be soluble in water, particularly in dianionic form 16 (Fig. 5) . The nitrogen and oxygen hydrogen-bond acceptor sites in 16 are preorganized for binding N-alkylguanidinium cations to form complex 17. Electronic interactions (conjugation) between the carboxylate groups and the neighboring pyridine rings should stabilize the coplanar conformation. Rotation about the pyridine-carboxylate bond is expected, but the symmetry of the carboxylate group produces identical structures via 180" rotation about this bond. The combination of receptor preorganization and attractive electrostatic interactions between the dianionic host and cationic guest led to our hypothesis that complexes of type 17 would be stable, even in aqueous media. The target arginine receptor was synthesized in seven steps as dipotassium salt 25 (Fig. 6) . The benzene ring of quinaldine (IS) was selectively reduced by catalytic hydrogenation in trifluoroacetic acid. Condensation of 19 with benzaldehyde in acetic anhydride gave dibenzylidene derivative 20, which was conveniently purified by vacuum distillation. Ozonolysis gave ketoaldehyde 21, which underwent Jones oxidation to ketoacid 22. Friedlhder condensation of 22 with 4-aminopyrimidine-5-carboxaldehyde gave 23, which was hydrolyzed to aminoaldehyde 24. A second condensation of 22 with 24 gave potassium salt 25, which was purified by recrystallization and obtained in 18% overall yield from quinaldine. The molecular symmetry of 25 results from the use of the same ketone (22) in both Friedlander condensations (e and g), but two different ketones could be used to make unsymmetrical molecules of type 25 bearing functional groups other than carboxylate. This route could also be used for the preparation of arginine receptors that are substituted to allow immobilization, attachment of other recognition sites or conjugation to biomolecules.
As anticipated, dipotassium salt 25 has relatively high solubility in water (ca. 0.3 M). It is slightly soluble in methanol and insoluble in dimethyl sulfoxide (DMSO), dichloromethane and chloroform. The corresponding carboxylic acid (15) has very low water solubility (ca. 4 pM), but is moderately soluble in DMSO. The ability of 25 to bind N-alkylguanidinium cations was tested by mixing an aqueous solidion of 25 with a dilute solution of ethylguanidine sulfate in water, resulting in the formation of a yellow precipitate. Crystals of this complex formed when a hot aqueous solution was cooled to room temperature but crumbled upon drying under vacuum or in air. According to results of combustion microanalysis and IH-NMR spectroscopy, dried samples of the complex consisted of the receptor dianion (16) and N-ethylguanidinium cation in 
CONCLUSION
Highly preorganized hexagonal lattice receptors can be designed and synthesized for complexation of biologically important molecules, such as urea, creatinine, guanidines and amino acids. The resulting complexes are exceptionally stable, even in competitive hydrogenbonding solvents, such as DMSO and water. Such artificial receptors can be used as extractants, chemosensors and probes for biological systems.
